Cancer cells gain many advantages over normal tissue by dysregulating calreticulin since it is a critical modulator of Ca2+ ion-dependent processes including proliferation, differentiation, cell adhesion, migration, intercellular interactions, immune response, and apoptosis [383,384,385,386,387,388,389,390]. This evidence concerns the gene CALR and cancer.